The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

A new Sen­ate bill is filled with calls for bet­ter pre­pared­ness for pan­demics go­ing for­ward

4 years ago

Covid-19 man­u­fac­tur­ing roundup: Con­struc­tion un­der­way on Mo­roc­co's $562M vac­cine plant; Ar­genti­na be­gins Sput­nik pro­duc­tion

4 years ago

I-Mab ex­pands man­u­fac­tur­ing for mul­ti­ple myelo­ma an­ti­body; Gran­ules is­sued 'mi­nor ob­ser­va­tion­s' af­ter in­spec­tion

4 years ago

Point un­veils new In­dy site to shore up sup­ply chain in fight against prostate can­cer

4 years ago
Pharma

Re­ci­phar­m's glob­al deal spree con­tin­ues with ac­qui­si­tion of Por­tuguese CD­MO

4 years ago

Mark Cuban's new cost-plus-15% gener­ic drug com­pa­ny is re­al­ly a com­pound­ing phar­ma­cy

4 years ago
Pharma

Trou­bled can­cer cen­ter in Con­necti­cut hand­ed Form 483 by FDA, again

4 years ago

Mas­sive $1.5B in­vest­ment in man­u­fac­tur­ing widens Eli Lil­ly's foot­print in Ire­land and North Car­oli­na

4 years ago

As pock­ets fill with cash, Mar­a­vai spends $240M to en­sure pure mR­NA pro­duc­tion

4 years ago

Ox­ford Bio­med­ica en­ters the AAV man­u­fac­tur­ing world, buy­ing Ho­mol­o­gy's in-house busi­ness

4 years ago
Deals
Cell/Gene Tx

Fu­ji­film ex­pands in US af­ter $100M deal for Atara's man­u­fac­tur­ing site and em­ploy­ees

4 years ago
Pharma

Can new man­u­fac­tur­ing ap­proach­es fi­nal­ly make a decades-old cell ther­a­py idea a re­al­i­ty?

4 years ago
Cell/Gene Tx

To ex­pand its oral and top­i­cal dosage op­tions, Catal­ent will put $10M in­to mi­croniza­tion

4 years ago

Covid-19 man­u­fac­tur­ing roundup: Brazil to man­u­fac­ture Vaxzevria at home; As­traZeneca ramp up in Spain gets the OK

4 years ago

Af­ter a ban­ner year, Sam­sung will charge for­ward with 'su­per plan­t' plans, and look to ex­pand abroad

4 years ago
Pharma

As Omi­cron-spe­cif­ic boost­ers are in the news, BioN­Tech to ex­pand Ger­man site work­force by 200 em­ploy­ees

4 years ago

Backed by Bay­er's Leaps, Boston-based Celli­no lands $80M for cell ther­a­py-in-box

4 years ago
Financing
Startups

FDA's do­mes­tic in­spec­tion hold will con­tin­ue un­til Feb­ru­ary

4 years ago

A Sen­ate bill wants to even an 'un­lev­el play­ing field' for do­mes­tic, for­eign in­spec­tion drop-ins amid back­log

4 years ago

Re­call re­port: Miss­ing la­bel, mi­cro­bial con­t­a­m­i­na­tion leads to re­call of two batch­es of two drugs

4 years ago

Man­u­fac­tur­ing woes con­tin­ue for Au­robindo af­ter FDA's warn­ing let­ter

4 years ago

Covid-19 man­u­fac­tur­ing roundup: New pro­duc­tion site opens in Africa; Sen­a­tor calls for test prices to be slashed

4 years ago

Johns Hop­kins and lo­cal biotech team up for new man­u­fac­tur­ing site; New oral drug plat­form to help ac­cel­er­ate R&D time­line

4 years ago

Fol­low­ing CRL, Re­vance says it's clear on in­struc­tions for re­sub­mit­ting BLA

4 years ago
First page Previous page 58596061626364 Next page Last page
A service from the Financial Times